Dr Anders Andreasson Professor John Dark
| Commentary: Revascularization of the Bronchial Arteries in Pulmonary Transplant; A Beautiful Description of a Redundant Procedure? | 2023 |
|
Dr Anders Andreasson Professor John Dark
| Revascularisation of the bronchial arteries in pulmonary transplant; does it ever have a role? | 2022 |
|
Dr Morvern Morrison Dr Anders Andreasson Catriona Charlton Dr Alisha Chhatwal Dr Bill Scott et al. | Transcriptional analysis identifies potential novel biomarkers associated with successful ex-vivo perfusion of human donor lungs | 2022 |
|
Kasim Jiwa Dr Lee Borthwick Dr Anders Andreasson Professor John Dark Professor Andrew Fisher et al. | Potential therapeutic benefits of the human amniotic epithelium cell secretome during ex-vivo perfusion of donor lungs | 2016 |
|
Dr Anders Andreasson Professor John Dark Professor Andrew Fisher
| Profiling Biomarkers of Inflammation and Tissue Injury during Human Ex Vivo Lung Perfusion in the DEVELOP-UK Study | 2016 |
|
Dr Anders Andreasson Danai Karamanou Dr Colin Gillespie Dr Lee Borthwick Kasim Jiwa et al. | Treating Donor Lung Inflammation by Blocking Interleukin-1B-An In Vitro Therapy Testing Platform for Ex Vivo Lung Perfusion | 2016 |
|
Dr Anders Andreasson Professor John Dark Professor Andrew Fisher
| Ultrastructural Changes in Epithelial and Endothelial Barriers During Ex-Vivo Lung Perfusion | 2015 |
|
Dr Anders Andreasson Professor John Dark Professor Andrew Fisher
| Ex vivo lung perfusion in clinical lung transplantation-State of the art | 2014 |
|
Dr Anders Andreasson Danai Karamanou Dr John Perry Dr Hannah Walden Stephen Clark et al. | The effect of ex vivo lung perfusion on microbial load in human donor lungs | 2014 |
|